GGrantIndex
Sort

11,323 grants matching glioblastoma

Cancer Stem Cell Niche in Brain Tumors

$312,983
Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2014 · CA

Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients

$312,894
Hyunsuk Shim · Emory University · R01 · FY2017 · CA

STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBM

$312,874
Amy Beth Heimberger · Northwestern University At Chicago · P50 · FY2024 · CA

Project 1: Proteomic approaches to target the PP6-mTORC2 pathway in glioblastoma

$312,854
Arminja Nadine Kettenbach · Dartmouth College · P20 · FY2017 · GM

Employing Humanized Microbiome Mice to Understand Immune Activation and Translational Therapeutic Potential in Glioblastoma

$312,852
Braden Cox McFarland · University Of Alabama At Birmingham · R01 · FY2024 · CA

NK Innate Immunity and Oncolytic Virus Therapy

$312,775
Michael A Caligiuri · Ohio State University · P01 · FY2013 · CA

Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9

$312,665
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2013 · NS

Temodar + O6-Benzylguanine Therapy in Malignant Glioma

$312,613
Duke University · R21 · FY2003 · CA

Therapy of Temodar plus O6-Benzylguanine in Malignant G*

$312,613
Duke University · R21 · FY2004 · CA

Toward a molecular classification of human gliomas

$312,600
Massachusetts General Hospital · R01 · FY2004 · CA

Engineering stem cell therapies to understand and overcome glioblastoma adaption

$312,561
Shawn Hingtgen · Univ Of North Carolina Chapel Hill · R01 · FY2018 · NS

Conditionally Replicative Adenoviral Vectors for Malignant Glioma

$312,556
Maciej S Lesniak · University Of Chicago · R01 · FY2009 · CA

BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma

$312,527
Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2019 · CA

Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer

$312,443
Karen Elizabeth Pollok · Indiana University Indianapolis · R01 · FY2012 · CA

Engineering fluorescence and magnetic resonance reporter genes for imaging biological function in hypoxic cells and in vivo

$312,398
Arnab Mukherjee · University Of California Santa Barbara · R35 · FY2021 · GM

Conditionally Replicative Adenoviral Vectors for Malignant Glioma

$312,391
Maciej S Lesniak · University Of Chicago · R01 · FY2010 · CA

OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy

$312,375
Balveen Kaur · Ohio State University · R01 · FY2012 · NS

OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy

$312,375
Balveen Kaur · Ohio State University · R01 · FY2011 · NS

Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer

$312,326
Karen Elizabeth Pollok · Indiana University Indianapolis · R01 · FY2011 · CA

Targeted Alpha-Particle Radiotheraphy of Brain Tumors with 211At-81C6 Antibody

$312,244
Michael Rod Zalutsky · Duke University · P50 · FY2016 · CA

Small Molecule Antibody Mimics: Toward a New Paradigm in Targeted Cancer Therapy

$312,233
David Adam Spiegel · Yale University · R01 · FY2013 · GM

Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide

$312,186
Duane A. Mitchell · Duke University · R01 · FY2011 · CA

Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide

$312,186
Duane A. Mitchell · Duke University · R01 · FY2012 · CA

Role of TFPI-2 in human gliomas invasiveness

$312,130
University Of Illinois At Chicago · R01 · FY2003 · CA

Role of TFPI-2 in human gliomas invasiveness

$312,130
University Of Illinois At Chicago · R01 · FY2004 · CA